American Society of Hirudotherapy

Adhesive Capsulitis (Frozen Shoulder)

Investigational adjunct in frozen shoulder; the only clinical reports identified are two single-patient case reports, with no controlled data.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for adhesive capsulitis (frozen shoulder). FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for frozen shoulder is investigational.
What evidence exists?
Tier C (investigational). Only two single-patient case reports of leech therapy for frozen shoulder were identified (2018 and 2022); no controlled study was found. There are no randomized controlled trials. Frozen shoulder is a self-limited condition (typical duration 12-30 months), which complicates uncontrolled outcome interpretation. Evidence-based first-line care includes physical therapy (stretching, mobilization), NSAIDs, intra-articular corticosteroid injection, hydrodilation, and — for refractory cases — manipulation under anesthesia or arthroscopic capsular release.
Main risks
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Bruising and tenderness over the shoulder for 5 to 10 days
  • Itching and irritation at bite sites
  • Local skin infection or, rarely, Aeromonas infection
  • Allergic reaction to leech saliva (uncommon)
  • Temporary worsening of shoulder pain or stiffness for 1 to 2 days
  • Small bite marks that usually fade over weeks to months (rarely a pale spot stays longer)
Who should not consider this
  • Patients on blood thinners (anticoagulants such as warfarin, DOACs or heparin)
  • Patients with hemophilia or other bleeding disorders
  • Patients with anemia
  • Patients with poorly controlled diabetes (diabetes worsens prognosis and infection risk)
  • Patients with active septic arthritis or local skin infection
  • Patients who have not engaged with physical therapy
  • Patients with a weakened immune system
What to ask your clinician
  • Have I been evaluated by orthopedics or sports medicine, and is the diagnosis confirmed (not impingement, rotator-cuff tear, or referred pain)?
  • Am I in the freezing, frozen, or thawing phase, and what is the right treatment for each?
  • Have I completed structured physical therapy, NSAIDs, and considered an intra-articular corticosteroid injection or hydrodilation?
  • What evidence supports leech therapy for adhesive capsulitis specifically?
  • Given my diabetes status (if applicable), how does this affect cellulitis risk?
  • What is the practitioner's experience and Aeromonas-prevention plan?
  • What is the cost?
When to seek urgent care
  • Fever, hot swollen shoulder joint (possible septic arthritis)
  • New severe shoulder pain after trauma (rule out fracture or tear)
  • Spreading redness, warmth, pus, or red streaks (cellulitis)
  • Bleeding from a bite site lasting more than 24 to 48 hours
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, throat tightness, or breathing difficulty

What this does NOT mean

  • This is not FDA-cleared for adhesive capsulitis.
  • Frozen shoulder is self-limited (12-30 months) — uncontrolled improvements cannot be attributed to therapy.
  • Mechanism rationale (local anti-inflammation) does NOT establish clinical efficacy.
  • Leech therapy will NOT release adhesions or replace capsular release in refractory cases.
  • Leech therapy is not a substitute for physical therapy and standard injections.

Clinical Profile

Category
Musculoskeletal
ICD-10
M75.00, M75.01, M75.02
Safety tier
Low

Evidence Summary

Adhesive capsulitis progresses through freezing, frozen, and thawing phases over 12-24 months. Standard management includes physiotherapy, intra-articular corticosteroid injection, and hydrodistension. No controlled clinical trial or case series of leech therapy for adhesive capsulitis was identified in PubMed, Europe PMC or trial registries. Two single-patient case reports exist (Kale and Agrawal 2018, a woman with diabetes; Dwivedi 2022, leech therapy combined with oral Ayurvedic medicines); both describe improved pain and range of motion without controls or validated scores. Use is investigational, with a speculative local anti-inflammatory rationale on capsular synovitis. Because the condition is largely self-limiting, any observed improvement could reflect natural disease progression rather than treatment effect.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Neither book writes about adhesive capsulitis (“frozen shoulder”) under this name; closest is humeroscapular periarthropathy (Duplay’s syndrome), which is described both by Baskova and Isakhanyan and by Michalsen et al.[B1][B3].
  • Baskova and Isakhanyan retell a report by Zhavoronkova (1998): combining leeches with reflexotherapy in Duplay’s syndrome, according to her data, gives a good clinical effect, lowers the risk of complications and improves the hemodynamic parameters of the blood[B1].
  • They also cite an observation by Frolov and Frolova (1999): leeches together with manual therapy were used in 29 patients with humeroscapular periarthropathy, and, according to the authors, the method proved effective; the assessment criteria and comparison group are not named in this account[B1].
  • Storck (chapter 6 of the book by Michalsen et al.) describes inflammation at the junctions of muscles and tendons with limited shoulder mobility and adhesions in the lower parts of the joint capsule, and calls this condition periarthropathy of the shoulder; leeches, in his words, can be included in the treatment plan together with massage, physical therapy and other measures that improve circulation, and he calls this at least as effective — what exactly this is compared with is not clear from the text, and he gives no figures or observational data[B3].
  • Among the contraindications, Baskova and Isakhanyan name, for example, hemophilia, anemias and concurrent use of anticoagulants; Michalsen et al. (chapter 8, Flecken and Michalsen) likewise regard taking anticoagulants as an absolute contraindication, and do not regard aspirin and clopidogrel as contraindications in themselves — in that case, in their words, fewer leeches are applied at the first leech treatment session[B1][B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Recent intra-articular corticosteroid injection (<4 weeks)
  • Glenohumeral joint instability or recent rotator cuff repair

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.